In vivo cytogenetic studies on rat's bone-marrow cells of structurally related Schiff base complexes

Drug and Chemical Toxicology

Volumn 34, Issue 1, 2011, Pages 92-99

  Saleh, Na'Il ^a,c   Khabour, Omar F ^b   Esmadi, Fatima T ^c   Al Kofahi, Etizaz ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c YARMOUK UNIVERSITY   (Jordan)

Author keywords

Bone marrow cells; Chromosome aberrations; Complex drug stability; In vivo cytogenetic study; N (8 quinolyl)napthaldimine; N (8 quinolyl)salicylaldimine; Structure activity relationship

Indexed keywords

ALDEHYDE; AROMATIC COMPOUND; DNA; FERRIC ION; IRON COMPLEX; METAL ION; N ( 8 QUINOLYL)NAPHTHALDIMINE; N ( 8 QUINOLYL)SALICYLALDIMINE; NAPHTHALENE DERIVATIVE; NICKEL; NICKEL COMPLEX; SALICYLIC ACID DERIVATIVE; SCHIFF BASE; UNCLASSIFIED DRUG;

ALKALINITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING SITE; BODY WEIGHT; BONE MARROW CELL; CHROMOSOME ABERRATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOGENETICS; DRUG ABSORPTION; DRUG CYTOTOXICITY; DRUG STABILITY; GENETIC TOXICOLOGY; GENOTOXICITY; IN VIVO STUDY; LIPOPHILICITY; MALE; METAL BINDING; MOLECULAR INTERACTION; NONHUMAN; RAT; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; LIGANDS; MALE; MITOTIC INDEX; MOLECULAR STRUCTURE; MUTAGENICITY TESTS; RATS; RATS, WISTAR; SCHIFF BASES; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; RATTUS;

EID: 78649913476     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480541003782302     Document Type: Article

References (30)

1. Azab, M., Khabour, O. F., Al-Omari, L., Alzubi, M. A., Alzoubi, K. (2009). Effect of every-other-day fasting on spontaneous chromosomal damage in rat's bone-marrow cells. J Toxicol Environ Health A 72:295-300.
2. Baillie, T. A. (2008). Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. Chem Res Toxicol 21:129-137.
3. Bonassia, S., Znaorb, A., Norppac, H., Hagmard, L. (2004). Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective. Cytogenet Genome Res 104:376-382.
4. Campo, V. L., Bernardes, L. S., Carvalho, I. (2009). Stereoselectivity in drug metabolism: molecular mechanisms and analytical methods. Curr Drug Metab 10:188-205.
5. Celik, A., Mazmanci, B., Camlica, Y., Kin, A. A., Comelekolu, U. (2003). Cytogenetic effects of lambda-cyhalothrin on Wistar rat bone marrow. Mutat Res 539:91-97.
6. Dharmaraj, N., Viswanathamurthi, P., Natarajan, K. (2001). Ruthenium (II) complexes containing bidentate Schiff bases and their antifungal activity. Trans Met Chem 26:105-109.
7. Djukic, B., Dube, P. A., Razavi, F., Seda, T., Jenkins, H. A., Britten, J. F., et al. (2009). Preparation and magnetic properties of Iron (3+) spin-crossover complexes bearing a thiophene substituent: toward multifunctional metallopolymers. Inorg Chem 48:699-707.
8. Esmadi, F. T., Irshaidat, T. Z. A. (2000). Reaction of some Schiff base complexes of iron (III) with nitrogen and sulfur donor anions. Synth React Inorg Met-Org Chem 30:1347-1362.
9. Esmadi, F. T., Irshiadat, T. (2001). Reactions of some Schiff base complexes of Cu (II) and Ni (II) with sulfur-donor anions. Asian J Chem 13:603-611.
10. Fita, P., Luzina, E., Dziembowska, T., Kopec, D., Piatkowski, P., Radzewicz, C., et al. (2005). Keto-enol tautomerism of two structurally related Schiff bases: direct and indirect way of creation of the excited keto tautomer. Chem Phys Lett 416:305-310.
11. Guo, L., Hong, S., Lin, X., Xie, Z., Chen, G. (2008). An organically modified sol-gel membrane for detection of lead ion by using 2-hydroxy-1-naphthaldehydene-8-aminoquinoline as fluorescence probe. Sens Actuators, B 130:789-794.
12. Hagmar, L., Stromberg, U., Bonassi, S., Hansteen, I., Knudsen, L. E. C., Lindholm, C., et al. (2004). Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res 64:2258-2263.
13. Hodnett, E. M., Mooney, P. D. (1970). Antitumor activities of some Schiff bases. J Med Chem 13:786.
14. Hoegberg, T., Rist, O., Hjelmencrantz, A., Moldt, P., Elling, C. E., Schwartz, T. W., et al. (2003). Metal ion binding-based chemical libraries useful for drug discovery processes. 7TM Pharma A/S, Den., Application: WO, p. 242.
15. Kaya, I., Vilayetoglu, A. R., Topak, H. (2002). Synthesis of oligoortho-azomethinephenol and its oligomer-metal complexes: characterization and application as antimicrobial agents. J Appl Polym Sci 85:2004-2013.
16. Lima, P. D. L., Vasconcellos, M. C., Montenegro, R. A., Sombra, C. M. L., Bahia, M. O., Costa-Lotufo, L. V., et al. (2008). Genotoxic and cytotoxic effects of iron sulfate in cultured human lymphocytes treated in different phases of cell cycle. Toxicol In Vitro 22:723-729.
17. M'Bemba-Meka, P., Lemieux, N., Chakrabarti, S. K. (2007). Role of oxidative stress and intracellular calcium in nickel carbonate hydroxide-induced sister-chromatid exchange and alterations in replication index and mitotic index in cultured human peripheral blood lymphocytes. Arch Toxicol 81:89-99.
18. Matskevich, T. N., Trailina, E. P., Nabokov, Y. S., Aptekar, M. D., Smolina, Z. V., Savich, I. A., et al. (1970). Biological activity of azomethine derivatives. Dokl Akad Nauk SSSR 190:104-107.
19. Norppa, H., Bonassi, S., Norppa, H., Bonassi, S., Hansteen, I.-L., Hagmar, L., et al. (2006). Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res 600:37-45.
20. Rist, O., Hoegberg, T., Holst Lange, B., Schwartz, T. W., Elling, C. E. (2003). Use of metal ion chelates in validating biological molecules as drug targets in test animal models. 7TM Pharma A/S, Den., Application: WO, p. 247.
21. Salman, S. R., Saleh, N. A. I. (1997). Calculation of tautomeric ratios of some Schiff bases using carbon-13 NMR spectroscopy. Can J Anal Sci Spectrosc 42:9-13.
22. Sandhar, R. K., Hothi, H. S., Sharma, J. R., Manrao, M. R. (2006). Synthesis and antifungal potential of Fe (III) complexes of 2-hydroxy-1- naphthalanilines. Pest Res J 18:4-6.
23. Seifried, H. E., Seifried, R. M., Clarke, J. J., Junghans, T. B., San, R. H. (2006). A compilation of two decades of mutagenicity test results with the Ames Salmonella typhimurium and L5178Y mouse lymphoma cell mutation assays. Chem Res Toxicol 19:627-644.
24. Seoane, A. I., Dulout, F. N. (2001). Genotoxic ability of cadmium, chromium, and nickel salts studied by kinetochore staining in the cytokinesis-blocked micronucleus assay. Mutat Res 490:99-106.
25. Testa, B., Kramer, S. D. (2009). The biochemistry of drug metabolism-an introduction: part 5. Metabolism and bioactivity. Chem Biodivers 6:591-684.
26. Thybaud, V., Aardema, M., Thybaud, V., Aardema, M., Clements, J., Dearfield, K., et al. (2007). Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing. Mutat Res 627:41-58.
27. Valeur, B. (2001). Molecular fluorescence: principles and applications. New York: Wiley-VCH.
28. Venkatachalam, G., Ramesh, R. (2005). Catalytic and biological activities of Ru (III) mixed ligand complexes containing N, O donor of 2-hydroxy-1-naphthylideneimines. Spectrochim Acta A Mol Biomol Spectrosc 61:2081-2087.
29. Vergnes, J. S., Ballantyne, B. (1998). Investigations on the in vitro and in vivo genotoxic potential of 5-vinyl-2-norbornene. J Appl Toxicol 18:129-142.
30. 2CO (HL = N-(8-quinolyl) salicylaldimine): synthesis, crystal structure, magnetic property, and DFT calculation. J Mol Struct 752:153-157.